Showing results (51-60 of 320) with videos related to
Sort By:
Pageof 32
Frontiers in Pharmacology|October 2, 2023
PEGylated exenatide injection (PB-119) improves beta-cell function and insulin resistance in treatment-naïve type 2 diabetes mellitus patientsXu Liu, Ling Song, Yuanhui Zhang, et al.Molecular Medicine Reports|July 22, 2017
Isorhamnetin inhibits IL‑1β‑induced expression of inflammatory mediators in human chondrocytesJin Li, Ruishan Wu, Xiaoping Qin, et al.Microbiological Research|September 25, 2016
Volatile organic compounds produced by Pseudomonas fluorescens WR-1 restrict the growth and virulence traits of Ralstonia solanacearumWaseem Raza, Ning Ling, Dongyang Liu, et al.Peerj|June 21, 2018
Highly efficient removal of ammonia nitrogen from wastewater by dielectrophoresis-enhanced adsorptionDongyang Liu, Chenyang Cui, Yanhong Wu, et al.Optics Express|February 14, 2023
Compact nanosecond Yb:YAG/V:YAG solid-state laser generating switchable radially and azimuthally beamsDongyang Liu, Bin Huang, Qian Yi, et al.Journal of Orthopaedic Surgery and Research|July 17, 2025
Timing optimization of teriparatide dosing for postmenopausal osteoporosis: a randomized controlled trialHuan Wang, Liyuan Tao, Dongyang Liu, et al.DNA and Cell Biology|June 28, 2023
Aquaporin 1 Facilitates Ferroptosis, M1 Polarization, Mitochondrial Dysfunction, and Autophagy Damage on Lipopolysaccharide-Induced Macrophage Through Down-Regulation of P53 Signaling PathwayWuyang Lv, Lei Liang, Dongyang Liu, et al.Clinical Pharmacology and Therapeutics|May 9, 2024
Application and Quality of Model-Based Meta-Analysis in Pharmaceutical Research: A Systematic Cross-Sectional Analysis and Practical ConsiderationsZhirong Yang, Hua He, Rui Wang, et al.Seminars in Arthritis and Rheumatism|October 22, 2023
Systematic review and model-based analysis to identify whether renal safety risks of URAT1 inhibitors are fully determined by uric acid-lowering efficaciesYuchen Qu, Yunli Yu, Jie Pan, et al.Pharmaceutics|August 28, 2025
Development of PBPK Population Model for End-Stage Renal Disease Patients to Inform OATP1B-, BCRP-, P-gp-, and CYP3A4-Mediated Drug Disposition with Individual Influencing FactorsYujie Wu, Weijie Kong, Jiayu Li, et al.Pageof 32